Selinexor Production Cost Reports

The report provides a detailed analysis essential for establishing a selinexor production plant. It encompasses all critical aspects necessary for selinexor production, including the cost of selinexor production, selinexor plant cost, selinexor production costs, and the overall selinexor production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a selinexor production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Selinexor is the first-in-class oral selective inhibitor that is FDA-approved for heavily pretreated relapsed or refractory multiple myeloma (RRMM). It is used in patients after at least four prior therapies that include proteasome inhibitors, immunomodulators, and anti-CD38 antibodies. It is used in combination with dexamethasone and bortezomib. It shows superior progression-free survival versus standard regimens after just one usage.

It is also approved for relapsed and refractory diffuse large B-cell lymphoma (DLBCL) after at least two prior systemic therapies. It is employed in penta-refractory myeloma and third-line lymphomas where traditional therapies fail due to its unique mechanism. It is also utilised in cytokine storm modulation in sepsis, Duchenne muscular dystrophy, and Parkinson's disease.

The market for selinexor is fuelled by its utilisation in heavily pretreated relapsed and refractory multiple myeloma (RRMM). Its usage in diffuse large B-cell lymphoma (DLBCL), along with its utilisation in combination with bortezomib and dexamethasone, contributes to its market growth. Its unique oral inhibition mechanism provides responses in penta-refractory cases, global approvals across many countries and strong progress in endometrial cancer, myelofibrosis, etc., boosting its market. Its efficacy in triple-class refractory settings, reimbursement challenges from high pricing, and payer ICER inquiry affect industrial selinexor procurement.  Other factors like GMP-compliant API sourcing from certified manufacturers, cost-effectiveness, tender pricing dynamics in competitive haematology-oncology markets, further influence its sourcing.

Raw Material for Selinexor Production

According to the selinexor production plant project report, the key raw materials used in the production of selinexor include polyfluorinated benzonitrile, DMF-derived reagent, hydrazine hydrate, halo ester, and aminopyrimidine.

Production Process of Selinexor

The extensive selinexor production cost report consists of the following major industrial production process:

1. From polyfluorinated benzonitrile: The production process of selinexor starts from a polyfluorinated benzonitrile. This is first converted to the corresponding benzamide intermediate through base-mediated transformation. The benzamide is then activated using a dimethylformamide-derived reagent to form an imidate or amidine-type intermediate. This intermediate goes through cyclocondensation with hydrazine hydrate to form the aryl-pyrazole core. This heterocycle is subjected to base-promoted N-alkylation with an activated halo ester to introduce an ester side chain, followed by hydrolysis to the corresponding carboxylic acid. The acid intermediate is then coupled with an aminopyrimidine fragment to form a key amide linkage, and final activation and condensation with the terminal amine fragment leads to the formation of selinexor.

Selinexor has the molecular formula of C17H11F6N7O with a molecular weight of MW 443.31 g/mol. It is a white to off-white crystalline solid with multiple polymorphs. It has a logP value of 3.0 with a topological polar surface area of 97.6 Ų, making it moderately orally permeable. It has 2 H-bond donors and 12 acceptors, 5-7 rotatable bonds, and 31 heavy atoms with low aqueous solubility. It has a vapour pressure of around 10^-¹¹ mmHg with a density of 1.6 g/cm³. It has a refractive index of 1.58 with a flash point above 150 degree Celsius.